HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperbaric oxygen therapy reduces mortality in patients with Fournier's Gangrene. Results from a multi-institutional observational study.

AbstractBACKGROUND:
Evidence about the clinical benefits of Hyperbaric Oxygen Therapy (HBOT) in patients with Fournier's Gangrene (FG) is controversial and inconclusive. We aimed to compare the mortality related to FG between patients undergoing surgical debridement and/or standard antibiotic therapy alone or in combination with HBOT.
METHODS:
We performed a retrospective multi-institutional observational case-control study. All patients admitted with diagnosis of FG from June 2009 to June 2019 were included into the study. Patients received surgical debridement and/or standard antibiotic therapy alone or in combination with HBOT. Factors associated with FG related mortality were assessed with uni-and multivariate analyses. The main outcome measure was FG related mortality.
RESULTS:
A total of 161 patients with diagnosis of FG were identified. Mean FG Severity Index was 8.6±4.5. All patients had broad-spectrum parenteral antibiotic therapy. An aggressive debridement was performed in 139 (86.3%) patients. A total of 72 patients (44.7%) underwent HBOT. Mortality due to FG was observed in 32 (36.0%) of patients who do not underwent HBOT and in 14 (19.4%) of patients who underwent HBOT (P=0.01). At the multivariate analysis, surgical debridement and HBOT were independent predictors of lower mortality while higher FG Severity Index was independent predictor of higher mortality.
CONCLUSIONS:
HBOT and surgical debridement are independent predictors of reduced FG related mortality.
AuthorsMassimiliano Creta, Nicola Longo, Davide Arcaniolo, Riccardo Giannella, Tommaso Cai, Annarita Cicalese, Cosimo De Nunzio, Giovanni Grimaldi, Virgilio Cicalese, Marco De Sio, Riccardo Autorino, Estevao Lima, Paolo Fedelini, Mariano Marmo, Marco Capece, Roberto La Rocca, Andrea Tubaro, Ciro Imbimbo, Vincenzo Mirone, Ferdinando Fusco
JournalMinerva urologica e nefrologica = The Italian journal of urology and nephrology (Minerva Urol Nefrol) Vol. 72 Issue 2 Pg. 223-228 (Apr 2020) ISSN: 1827-1758 [Electronic] Italy
PMID32083420 (Publication Type: Journal Article, Multicenter Study, Observational Study)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents (therapeutic use)
  • Case-Control Studies
  • Combined Modality Therapy
  • Debridement
  • Female
  • Fournier Gangrene (mortality, surgery, therapy)
  • Humans
  • Hyperbaric Oxygenation (methods)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: